Invest and Sell MycoWorks Stock

MycoWorks Funding Rounds and Valuation

Funding History Chart

Funding Round Details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	10/18/2022	Series C-2	$37.05MM	$xx.xx	$517.12MM	GM Ventures, SOSV
Price per Share $xx.xx Shares Outstanding 8,509,417 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors GM Ventures, SOSV
	01/13/2022	Series C	$126.25MM	$xx.xx	$455.29MM	Prime Movers Lab, SK Networks, Mirabaud Lifestyle Impact & Innovation Fund, DCVC Bio, Novo Holdings
Price per Share $xx.xx Shares Outstanding 31,970,000 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors Prime Movers Lab, SK Networks, Mirabaud Lifestyle Impact & Innovation Fund, DCVC Bio, Novo Holdings
	11/17/2020	Series B-2	$5MM	$xx.xx	$136.2MM	WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend
Price per Share $xx.xx Shares Outstanding 3,776,079 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend
	11/17/2020	Series B-1	$45MM	$xx.xx	$136.2MM	WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend
Price per Share $xx.xx Shares Outstanding 25,490,000 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors WTT Investment Ltd., DCVC Bio, Valor Equity Partners, Humboldt Fund, Gruss & Co., Novo Holdings, 8VC, SOSV, AgFunder, Wireframe Ventures, Tony Fadell, Natalie Portman, John Legend
	05/08/2019	Series A-3	$623,858	$xx.xx	$29.56MM	DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
Price per Share $xx.xx Shares Outstanding 1,001,378 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
	05/08/2019	Series A-2	$1.84MM	$xx.xx	$29.56MM	DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
Price per Share $xx.xx Shares Outstanding 4,176,623 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
	05/08/2019	Series A-1	$154,478	$xx.xx	$29.56MM	DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
Price per Share $xx.xx Shares Outstanding 1,180,129 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
	05/08/2019	Series A	$11.31MM	$xx.xx	$29.56MM	DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures
Price per Share $xx.xx Shares Outstanding 14,521,047 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 6.0% Cumulative Non-cumulative Participating Non-participating Participation Cap N/A Key Investors DCVC Bio, Novo Holdings, 8VC, Future Tech Labs, AgFunder, Susa Ventures, Cthulhu Ventures, Wireframe Ventures

Access Stock Price

Leadership & Board

Leadership

Matthew Scullin Ph.D

Chief Executive Officer & Board Member

Douglas Hardesty

Chief Operating Officer

Philip Ross

Co-Founder, Chief Technology Officer & Board Member

Mike Todd

Chief of Product

Janne Kerovuo Ph.D

Chief Science Officer

Board

Anders Spohr Ph.D

Novo Holdings

Kiersten Stead Ph.D

DCVC Bio

MycoWorks stock FAQs

Can you buy MycoWorks stock?

As MycoWorks is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like MycoWorks, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy MycoWorks stock?

To invest in a private company like MycoWorks through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell MycoWorks stock?

Yes, you may sell the MycoWorks stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell MycoWorks stock?

If you hold private company shares of MycoWorks – whether as an employee or an early investor – Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your MycoWorks on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is MycoWorks a public company?

No, MycoWorks is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is MycoWorks’ stock price?

MycoWorks is a privately held company and therefore does not have a public stock price. However, you may access MycoWorks private market stock price with Forge Data.

What is MycoWorks’ stock ticker symbol?

MycoWorks does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

MycoWorks’ news and media highlights

Blog

Startup News: Private Companies Generating Eco-Friendly Alternatives to Traditional Products

January 25, 2023

Venture capitalists increasingly seek opportunities to make “green’’ investments in both private and public markets, and these companies fit the bill.

Forbes 01/17/2023

From Art To Bioengineering: How MycoWorks’ Creative Heritage Guides Its Growth

Artistry and craft are the foundation of MycoWorks, a biomaterials company partnering with some of today’s leading fashion brands. According to its artist-founders, Phil Ross and Sophia Wang, these core values lend them a competitive edge in a high-tech industry.

The New York Times 12/25/2022

Are Mushrooms the Future of Alternative Leather?

MycoWorks uses mycelium, the substance in the root structure of mushrooms, to make Reishi, which has the look and feel of leather. Big-name companies are very interested.

Browse More Insights

Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

MycoWorks Stock

Register To Buy and Sell Private Company Shares

Enterprise Value

Access MycoWorks’ valuation and stock price.

MycoWorks Stock Price